| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/28/2000 | WO2000078990A2 Search method for resistance to anti-proteases of a strain of the hiv 2 virus from a biological sample taken from a patient |
| 12/28/2000 | WO2000078986A1 Regulation system of expression using nuclear ppar receptors |
| 12/28/2000 | WO2000078977A1 Novel vectors for improving cloning and expression in low copy number plasmids |
| 12/28/2000 | WO2000078973A1 Process for oxidising aromatic compounds |
| 12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
| 12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
| 12/28/2000 | WO2000078970A1 Nucleic and proteinic acids corresponding to human gene abc1 |
| 12/28/2000 | WO2000078955A1 Epithelial cell growth inhibitors |
| 12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078949A1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 12/28/2000 | WO2000078947A1 Head trauma induced cytoplasmatic calcium binding protein |
| 12/28/2000 | WO2000078945A1 Methods of enriching for and identifying polymorphisms |
| 12/28/2000 | WO2000078944A1 Methods to design and identify new plant resistance genes |
| 12/28/2000 | WO2000078943A2 EXPANSION OF A NOVEL CAG TRINUCLEOTIDE REPEAT IN THE 5' REGION OF THE PROTEIN PHOSPHATASE 2A PPP2R2Bβ GENE IS ASSOCIATED WITH SCA12 |
| 12/28/2000 | WO2000078942A1 Non-destructive cell-based assay |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078933A2 Novel calpains and their use |
| 12/28/2000 | WO2000078919A1 Method and apparatus for the detection of volatile products in a sample |
| 12/28/2000 | WO2000078806A1 Mage-a1 peptides presented by hla class ii molecules |
| 12/28/2000 | WO2000078802A2 Secreted polypeptides and corresponding polynucleotides |
| 12/28/2000 | WO2000078788A1 NOVEL cDNA ASSOCIATED WITH RENAL DISEASE |
| 12/28/2000 | WO2000078781A1 Detection of giardia |
| 12/28/2000 | WO2000078452A1 Device for implementing an analysis pack, analysis pack and method using same |
| 12/28/2000 | WO2000078364A2 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 12/28/2000 | WO2000078363A1 Radiolabeled farnesyl-protein transferase inhibitors |
| 12/28/2000 | WO2000078342A1 Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases |
| 12/28/2000 | WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/28/2000 | WO2000058460A3 Casb619 involved in colon cancers |
| 12/28/2000 | WO2000058439A3 Screening methods for compounds that inhibit or stimulate helicase enzyme activity |
| 12/28/2000 | WO2000056872A3 High-throughput gene cloning and phenotypic screening |
| 12/28/2000 | WO2000055360A3 Method for the determination of alterations in the sequence of dna molecules using multiple-dye cflp (md-cflp) |
| 12/28/2000 | WO2000052203A3 Identification of bacteria by amplification and probing |
| 12/28/2000 | WO2000052202A3 Detection of monilinia spp. using the polymerase chain reaction |
| 12/28/2000 | WO2000049162A3 Compositions and methods for non-targeted activation of endogenous genes |
| 12/28/2000 | WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes |
| 12/28/2000 | WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | WO2000040593A3 Target molecule attachment to surfaces |
| 12/28/2000 | WO2000037640A3 Compositions and methods for the treatment of tumor |
| 12/28/2000 | WO2000035465A3 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
| 12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
| 12/28/2000 | DE19928887A1 Assessing microbial contamination of a flat material, e.g. food packaging, comprises moving a microorganism-collecting device relative to the material to strip microorganisms from it |
| 12/28/2000 | CA2378051A1 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 12/28/2000 | CA2377707A1 Improved primers and methods for the detection and discrimination of nucleic acids |
| 12/28/2000 | CA2377263A1 Polynucleotides and polypeptides encoded thereby |
| 12/28/2000 | CA2376782A1 Device for implementing an analysis pack, analysis pack and method using same |
| 12/28/2000 | CA2375911A1 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 12/28/2000 | CA2375905A1 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 12/28/2000 | CA2375890A1 Process for removing systematic error and outlier data and for estimating random error in chemical and biological assays |
| 12/28/2000 | CA2375869A1 Regulation system of expression using nuclear ppar receptors |
| 12/28/2000 | CA2375821A1 Novel vectors for improving cloning and expression in low copy number plasmids |
| 12/28/2000 | CA2375798A1 Capillary electrophoresis method for screening for affinity ligands using a detectable competitive ligand |
| 12/28/2000 | CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci |
| 12/28/2000 | CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1 |
| 12/28/2000 | CA2375550A1 Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample |
| 12/28/2000 | CA2375542A1 Compositions and methods for assaying subcellular conditions and processes energy transfer |
| 12/28/2000 | CA2375508A1 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | CA2375498A1 Epithelial cell growth inhibitors |
| 12/28/2000 | CA2375493A1 Human transport proteins |
| 12/28/2000 | CA2375480A1 Head trauma induced cytoplasmatic calcium binding protein |
| 12/28/2000 | CA2375477A1 Novel calpains and their use |
| 12/28/2000 | CA2375414A1 Human transcriptional regulator proteins |
| 12/28/2000 | CA2375407A1 Rna metabolism proteins |
| 12/28/2000 | CA2375302A1 Electrochemical sensor for analysis of liquid samples |
| 12/28/2000 | CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/27/2000 | EP1063301A2 Substrate carrying immobilised nucleic acid molecules |
| 12/27/2000 | EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1063286A1 Substrates for immobilizing and amplifying dna, dna-immobilized chips having dna immobilized on the substrates, and method for amplifying dna |
| 12/27/2000 | EP1062840A1 Apparatus and method for a custom soft-solid hearing aid |
| 12/27/2000 | EP1062614A1 Methods for making character strings, polynucleotides and polypeptides |
| 12/27/2000 | EP1062517A2 Diagnosis of spongiform encephalopathies using prionins |
| 12/27/2000 | EP1062515A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 12/27/2000 | EP1062514A2 C-myc coding region determinant-binding protein (crd-bp) |
| 12/27/2000 | EP1062513A1 Method for detecting microbes from an enrichment culture |
| 12/27/2000 | EP1062500A1 Method for regulating the sensitivity of a microsensor, and a microsensor that makes use of this method |
| 12/27/2000 | EP1062368A1 Protein interaction and transcription factor trap |
| 12/27/2000 | EP1062367A1 Zymogenic nucleic acid detection methods, and related molecules and kits |
| 12/27/2000 | EP1062366A1 Detection of neoplasia by analysis of saliva |
| 12/27/2000 | EP1062365A1 Detection of fermentation-related microorganisms |
| 12/27/2000 | EP1062364A1 Qualitative differential screening |
| 12/27/2000 | EP1062363A1 Method for producing agents for treating tumour diseases and for immunosuppression |
| 12/27/2000 | EP1062361A2 Water-soluble coumarin fluorescent enzyme substrates |
| 12/27/2000 | EP1062360A1 Compositions and methods for enhanced synthesis of nucleic acid molecules |
| 12/27/2000 | EP1062347A1 Diagnostics and vaccines for mycobacterial infections of animals and humans |
| 12/27/2000 | EP1062346A1 Gene encoding labyrinthin, a marker for cancer |
| 12/27/2000 | EP1062345A1 Biosynthetic genes for spinosyn insecticide production |
| 12/27/2000 | EP1062344A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 12/27/2000 | EP1062339A2 Human fgf gene and gene expression products |
| 12/27/2000 | EP1062338A2 Human membrane spanning proteins |
| 12/27/2000 | EP1062334A1 Mammalian sodium channel proteins |
| 12/27/2000 | EP1062332A2 Human receptor proteins; related reagents and methods |
| 12/27/2000 | EP1062331A1 Compounds related to pap-1 |
| 12/27/2000 | EP1062326A1 Glycosyl sulfotransferase-3 |
| 12/27/2000 | EP1062323A2 Methods of diagnosis and triage using cell activation measures |
| 12/27/2000 | EP1062319A1 Vascular endothelial growth factor 2 |
| 12/27/2000 | EP1062246A1 Anti-inositolphosphoglycan monoclonal antibodies |